Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.19.8107

Autophagy Involvement in Olanzapine-Mediated Cytotoxic Effects in Human Glioma Cells  

Wang, Yi-Xuan (Department of Pharmacology, School of Pharmaceutical Sciences, Soochow University)
Xu, Shu-Qing (Department of Pharmacology, School of Pharmaceutical Sciences, Soochow University)
Chen, Xiang-Hui (Department of Pharmacology, School of Pharmaceutical Sciences, Soochow University)
Liu, Rui-Si (Department of Pharmacology, School of Pharmaceutical Sciences, Soochow University)
Liang, Zhong-Qin (Department of Pharmacology, School of Pharmaceutical Sciences, Soochow University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.19, 2014 , pp. 8107-8113 More about this Journal
Abstract
The aim of this study was to investigate the effects of olanzapine on growth inhibition as well as autophagy in glioma cells in vitro and in vivo. The proliferation of both LN229 and T98 glioma cells, measured by MTT assay, was suppressed in a concentration-dependent and time-dependent manner. Moreover, apoptosis of both cells was significantly increased with the treatment of olanzapine as evidenced by increased Bcl-2 expression, Hoechst 33258 staining and annexinV-FITC/PI staining. Olanzapine treatment also enhanced activation of autophagy with increased expression of LC3-II, expression of protein p62, a substrate of autophagy, being decreased. The growth inhibition by olanzapine in both glioma cell lines could be blocked by co-treatment with 3-MA, an autophagy inhibitor. Furthermore, olanzapine effectively blocked the growth of subcutaneous xenografts of LN229 glioma cells in vivo. The increased level of protein LC3-II and decreased level of p62 followed by a decreased level of Bcl-2, suggesting that autophagy may contribute to apoptosis. In addition, reduced proliferation of glioma cells was shown by a decrease of Ki-67 staining and increased caspase-3 staining indicative of apoptosis in mouse xenografts. These results indicated that olanzapine inhibited the growth of glioma cells accompanied by induction of autophagy and apoptosis both in vitro and in vivo. Olanzapine-induced autophagy plays a tumor-suppressing role in glioma cells.
Keywords
Olanzapine; autophagy; apoptosis; glioma; xenograft;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Alers S, Loffler AS, Wesselborg S, Stork B (2012). Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol, 32, 2-11.   DOI
2 Bialik S, Kimchi A (2010). Lethal weapons: DAP-kinase, autophagy and cell death: DAP-kinase regulates autophagy. Curr Opin Cell Biol, 22, 199-205.   DOI   ScienceOn
3 Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.   DOI   ScienceOn
4 Cohrs S (2008). Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs, 22, 939-62.   DOI
5 Errafiy R, Aguado C, Ghislat G, et al (2013). PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity. PLoS One, 8, 83318.   DOI
6 Fioretti B, Catacuzzeno L, Sforna L, et al (2009). Histamine hyperpolarizes human glioblastoma cells by activating the intermediate-conductance $Ca_2$-activated K+ channel. Am J Physiol Cell Physiol, 297, C102-10.   DOI
7 Katsetos CD, Draberova E, Smejkalova B, et al (2007). Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells. Neurochem Res, 32, 1387-98.   DOI
8 Kirk SL, Glazebrook J, Grayson B, Neill JC, Reynolds GP (2009). Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacology, 207, 119-25.   DOI
9 Levine B, Kroemer G (2008). Autophagy in the pathogenesis of disease. Cell, 132, 27-42.   DOI   ScienceOn
10 Li L, Kracht J, Peng S, Bernhardt G, Buschauer A (2003). Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine. Bioorg Med Chem Lett, 13, 1245-8.   DOI
11 Liang C, Feng P, Ku B, et al (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol, 8, 688-99.   DOI   ScienceOn
12 Liang J, Shao SH, Xu ZX, et al (2007). The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol, 9, 218-24.   DOI   ScienceOn
13 Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008). Autophagy fights disease through cellular self-digestion. Nature, 451, 1069-75.   DOI   ScienceOn
14 Lum JJ, Bauer DE, Kong M, et al (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 120, 237-48.   DOI   ScienceOn
15 Luo Z, Zang M, Guo W (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol, 6, 457-70.   DOI   ScienceOn
16 Mathew R, Karantza-Wadsworth V, White E (2007). Role of autophagy in cancer. Nat Rev Cancer, 7, 961-7.   DOI   ScienceOn
17 Navari RM (2014). Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting. Eur J Pharmacol, 722, 180-6.   DOI
18 Nicolau-Galmes F, Asumendi A, Alonso-Tejerina E, et al (2011). Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. Apoptosis, 16, 1253-67.   DOI
19 Pandey S, Chandravati (2012). Autophagy in cervical cancer: an emerging therapeutic target. Asian Pac J Cancer Prev, 13, 4867-71.   DOI   ScienceOn
20 Rabinowitz JD, White E (2010). Autophagy and metabolism. Science, 330, 1344-8.   DOI   ScienceOn
21 Ryu CH, Yoon WS, Park KY, et al (2012). Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells. J Biomed Biotechnol, 2012, 987495.
22 Schmidt RH, Jokinen JD, Massey VL, et al (2013). Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs. J Pharmacol Exp Ther, 347, 126-35.   DOI
23 Yang Z, Klionsky DJ (2010). Eaten alive: a history of macroautophagy. Nat Cell Biol, 12, 814-22.   DOI   ScienceOn
24 Skrede S, Martins L, Berge RK, et al (2014). Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects. Int J Neuropsychopharmacol, 17, 91-104.   DOI
25 Stupp R, Hegi ME, Mason WP, et al (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol, 10, 459-66.   DOI
26 Wang JB, Dong DF, Wang MD, Gao K (2014). IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in glioma cells in vitro and in vivo. Asian Pac J Cancer Prev, 15, 427-32.   DOI
27 Zhang JP, Gallego JA, Robinson DG, et al (2013). Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol, 16, 1205-18.   DOI
28 Zhuang W, Li B, Long L, et al (2011). Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer, 129, 2720-31.   DOI
29 Zhang WB, Wang Z, Shu F, et al (2010). Activation of AMPactivated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J Biol Chem, 285, 40461-71.   DOI
30 Zhou X, Ikenoue T, Chen X, et al (2009). Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy. Proc Natl Acad Sci USA, 106, 8923-8.   DOI   ScienceOn